Drug or treatment

Teplizumab clinical trials

• 7Clinical trials
• 21Countries

Newest trials

All recruiting trials (7)

• Real-world outcomes for people with Type 1 diabetes treated with teplizumab through managed access programs

  This project will look at health records to see how teplizumab is being used and how people's Type 1 diabetes progressed after receiving it through managed access programs.

  Recruiting at 2 sites Sanofi · Leuven and 15 other locations · NCT07457580

• Long-term outcomes of teplizumab in routine care

  This project will see if teplizumab given to people with Stage 2 Type 1 Diabetes delays the start of Stage 3 diabetes and how it affects their quality of life over time.

  Recruiting at 12 sites Sanofi · Washington D.C., District of Columbia and 11 other locations · NCT07360080

• Real-world comparison of experiences for people with stage 2 type 1 diabetes who did or did not receive teplizumab

  This study will compare real-world experiences, quality of life, and disease progression for people aged 8 and older with stage 2 type 1 diabetes who received teplizumab versus similar people who did not.

  Recruiting Sanofi · San Francisco, California · NCT07260110

• Teplizumab versus ATG to delay Stage 3 type 1 diabetes

  This trial tests whether ATG can delay or prevent Stage 3 type 1 diabetes as well as or better than teplizumab in people aged 4 to 34 with Stage 2 disease.

  Recruiting at 6 sites Phase 2 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Aurora, Colorado and 5 other locations · NCT07216391

• Teplizumab versus placebo for recent-onset Stage 3 Type 1 diabetes in people aged 1–25

  This will test whether an IV course of teplizumab can improve blood sugar control and reduce the need for mealtime insulin over one year in people aged 1–25 who were recently diagnosed with stage 3 type 1 diabetes.

  Recruiting at 202 sites Phase 3 Sanofi · Scottsdale, Arizona and 201 other locations · NCT07088068

• Registry for patients with Stage 2 Type 1 Diabetes

  This study is looking to see how well the treatment TZIELD can help people with Stage 2 Type 1 Diabetes by tracking their health over time compared to those who aren't using the treatment.

  Recruiting at 37 sites Sanofi · Los Angeles, California and 36 other locations · NCT06481904

• Impact of GLP-1Ra on Metabolic Outcomes in Early Stage Type 1 Diabetes

  This study is testing if a new diabetes drug can help people with early stage Type 1 Diabetes improve their blood sugar control and heart health while they are also getting another treatment.

  Recruiting Early Phase 1 Vanderbilt University Medical Center · Nashville, Tennessee · NCT06338553

Quick answers

How many clinical trials of Teplizumab are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 21 countries. The most sites are in United States (6 trials), Germany (3 trials), Israel (2 trials), Belgium (2 trials), France (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 1, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →